Live Research Database
Psoriasis
Hub: Arlington, TX
Connecting patients in Arlington with breakthrough clinical trials, specialized care, and study-related compensation.
+4k
Join 4,200+ participants tracking trials in Texas
Available Psoriasis Opportunities
3 RecruitingNCT07340216(Verify)
Maximal Usage Pharmacokinetics and Safety Study of ARQ-154 Foam 0.3% in Pediatric Participants With Scalp and Body Psoriasis
RECRUITING
Psoriasis
NCT07116967(Verify)
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
RECRUITING
Psoriasis
NCT06425549(Verify)
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis
RECRUITING
Psoriasis
Patient Safeguards
IRB Oversight
Ethics Committee Approved
HIPAA Compliant
Full Data Privacy
NIH Standards
Global Quality Benchmarks
"Advancing Psoriasis research in Arlington through safe, transparent, and patient-first clinical trials."
Research Hubs in Arlington
Explore other local breakthroughs
Psoriasis Hubs in TX
Regional Network of Excellence
ClinicalTrials.govFDA REGISTEREDIRB OVERSIGHTHIPAA COMPLIANT